Inibitori monoclonali di PCSK9: Dati attuali e prospettive future della terapia ipolipemizzante alla luce di quanto emerso finora dal programma ODYSSEY

Translated title of the contribution: PCSK9 monoclonal antibody inhibition: Current evidence and future perspectives of lipid-lowering therapy according to the available results from the ODYSSEY program

Research output: Contribution to journalArticle

Translated title of the contributionPCSK9 monoclonal antibody inhibition: Current evidence and future perspectives of lipid-lowering therapy according to the available results from the ODYSSEY program
Original languageItalian
Pages (from-to)211-216
Number of pages6
JournalGiornale Italiano di Cardiologia
Volume16
Issue number4
Publication statusPublished - Apr 1 2015

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this